Article
The changing burden of hepatitis C virus infection in the United States: model-based predictions.
Annals of internal medicine - 5 Aug 2014
Kabiri Mina, Jazwinski Alison B, Roberts Mark S, Schaefer Andrew J, Chhatwal Jagpreet
Abstract excerpt
BACKGROUND: Chronic hepatitis C virus (HCV) infection causes a substantial health and economic burden in the United States. With the availability of direct-acting antiviral agents, recently approved therapies and those under development, and 1-time birth-cohort screening, the burden of this disease is expected to decrease. OBJECTIVE: To predict the effect of new therapies and screening on chronic HCV infection...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
